Nohla Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Out of Business

Nohla Therapeutics General Information

Description

Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical diseases. The company's products are based on a unique umbilical cord blood expansion platform, providing doctors the functional support of bone marrow in response to each patient's unique blood-production needs, without any requirement for HLA matching.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 1600 Fairview Avenue East
  • Suite 100
  • Seattle, WA 98102
  • United States
+1 (206) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nohla Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Nov-2019 00000 Completed Out of Business
4. Early Stage VC (Series B) 12-Jul-2018 0000 00000 Completed Clinical Trials - Phase 2
3. Grant 28-Sep-2017 00.00 000.00 Completed Startup
2. Early Stage VC (Series A) 29-Nov-2016 $43.5M $64.5M 00000 Completed Startup
1. Corporate 24-Dec-2015 $21M $21M Completed Startup
To view Nohla Therapeutics’s complete valuation and funding history, request access »

Nohla Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Nohla Therapeutics’s complete cap table history, request access »

Nohla Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical
Biotechnology
Seattle, WA
43 As of 2018
00000
00000000 00 00000

00000

t nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000000000000
Waltham, MA
000 As of 0000
00000
00000000 00000

000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
0000 000000000
New York, NY
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nohla Therapeutics Competitors (49)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TScan Therapeutics Formerly VC-backed Waltham, MA 000 00000 00000000 00000
Aurora Biopharma Angel-Backed New York, NY 00000 0000000000 00000
PHAXIAM Therapeutics Formerly VC-backed Lyon, France 00 00000 00000000 00000
Carisma Therapeutics Formerly VC-backed Philadelphia, PA 00 00000 000000000 00000
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 49 competitors. Get the full list »

Nohla Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nohla Therapeutics FAQs

  • When was Nohla Therapeutics founded?

    Nohla Therapeutics was founded in 2015.

  • Who is the founder of Nohla Therapeutics?

    Colleen Delaney MD is the founder of Nohla Therapeutics.

  • Where is Nohla Therapeutics headquartered?

    Nohla Therapeutics is headquartered in Seattle, WA.

  • What is the size of Nohla Therapeutics?

    Nohla Therapeutics has 43 total employees.

  • What industry is Nohla Therapeutics in?

    Nohla Therapeutics’s primary industry is Biotechnology.

  • Is Nohla Therapeutics a private or public company?

    Nohla Therapeutics is a Private company.

  • What is Nohla Therapeutics’s current revenue?

    The current revenue for Nohla Therapeutics is 000000.

  • How much funding has Nohla Therapeutics raised over time?

    Nohla Therapeutics has raised $120M.

  • Who are Nohla Therapeutics’s competitors?

    TScan Therapeutics, Aurora Biopharma, PHAXIAM Therapeutics, Carisma Therapeutics, and NexImmune are some of the 49 competitors of Nohla Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »